|
UBLCP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.814950E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.158700E-04 |
| Normal-vs-Stage2 |
3.061600E-01 |
| Normal-vs-Stage3 |
2.798400E-04 |
| Normal-vs-Stage4 |
1.082490E-03 |
| Stage1-vs-Stage2 |
5.510000E-01 |
| Stage1-vs-Stage3 |
2.256600E-01 |
| Stage1-vs-Stage4 |
3.985200E-01 |
| Stage2-vs-Stage3 |
2.609000E-01 |
| Stage2-vs-Stage4 |
3.515600E-01 |
| Stage3-vs-Stage4 |
7.521000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.807500E-04 |
| Normal-vs-AfricanAmerican |
3.774900E-04 |
| Normal-vs-Asian |
2.392800E-01 |
| Caucasian-vs-AfricanAmerican |
3.180600E-01 |
| Caucasian-vs-Asian |
9.058000E-01 |
| AfricanAmerican-vs-Asian |
5.935800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.045100E-04 |
| Normal-vs-Female |
4.965000E-04 |
| Male-vs-Female |
7.701800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.216400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.959940E-03 |
| Normal-vs-Age(61-80Yrs) |
5.230400E-04 |
| Normal-vs-Age(81-100Yrs) |
8.864000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.589800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.490200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.403400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.863200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.361600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.311600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.866400E-01 |
| Normal-vs-Grade 2 |
2.009800E-02 |
| Normal-vs-Grade 3 |
1.50195999999436E-05 |
| Normal-vs-Grade 4 |
1.013050E-04 |
| Grade 1-vs-Grade 2 |
8.161600E-01 |
| Grade 1-vs-Grade 3 |
2.661400E-01 |
| Grade 1-vs-Grade 4 |
2.153000E-01 |
| Grade 2-vs-Grade 3 |
5.510000E-02 |
| Grade 2-vs-Grade 4 |
4.215800E-02 |
| Grade 3-vs-Grade 4 |
4.493800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.453700E-02 |
| Normal-vs-ccB subtype |
1.191930E-04 |
| ccA subtype-vs-ccB subtype |
3.616300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.319500E-03 |
| Normal-vs-N1 |
2.556200E-02 |
| N0-vs-N1 |
6.002200E-01 |
|
|
